Blood pressures, heart rate and locomotor activity during salt loading and angiotensin II infusion in protease-activated receptor 2 (PAR2) knockout mice.

John J McGuire, Bruce N Van Vliet, Sarah J Halfyard
Author Information
  1. John J McGuire: Cardiovascular Research Group, Division of BioMedical Sciences, Faculty of Medicine, Memorial University, St. John's, Newfoundland, Canada. mcguire@mun.ca

Abstract

BACKGROUND: In this study we used radiotelemetry to measure hemodynamic variables and locomotor activity in conscious unrestrained male Protease-Activated Receptor 2 (PAR-2) knockout mice in order to provide a detailed assessment of their blood pressure phenotype. In addition we tested for an influence of PAR-2 on salt-sensitivity (8% versus 0.5% NaCl diet, 2.5 weeks) and angiotensin II-induced hypertension (1 microg Ile5-angiotensin II/kg/min versus 0.25 microl/h saline, 2 weeks).
RESULTS: Systolic arterial pressures of PAR-2 -/- (129 +/- 1 mmHg, n = 21, P < 0.05) were statistically higher than those of C57BL/6J (124 +/- 1 mmHg, n = 33) throughout the 24 h period under baseline conditions. Pulse pressures in PAR-2 -/- were also significantly elevated (33 +/- 1 mmHg versus 30 +/- 1 mmHg, P < 0.05), whereas diastolic arterial pressures were not. Heart rates in PAR-2 -/- were not significantly different than controls, with the exception that heart rate of PAR-2 -/- was 23 beats per min higher than controls (P < 0.001) during periods of nocturnal activity. The diurnal pattern and intensity of locomotor activity were not found to differ between strains. A high salt diet led to increased blood pressures, decreased heart rates, increased time spent active and decreased intensity levels of locomotor activity. Salt-induced changes in systolic and pulse pressures in PAR-2 -/- were less than in C57B/6J. Angiotensin II treatment increased pressures, decreased heart rates, decreased time spent active and decreased intensity levels of activity of PAR-2 -/-, all to the same extent as C57BL/6J. A trend of lower blood pressures during the middle period of angiotensin II treatment period was observed in individual PAR-2 -/-.
CONCLUSION: The data indicated gene knockout of PAR-2 was associated with a modest change in blood pressure phenotype. PAR-2 -/- mice exhibited moderate elevation of systolic arterial and pulse pressures, yet no increased diastolic arterial pressure, no increased blood pressure responses to high salt diet and a subtle difference in the time course of the blood pressure responses to angiotensin II infusion.

References

  1. Crit Rev Clin Lab Sci. 2003 Feb;40(1):43-115 [PMID: 12627748]
  2. Am J Pathol. 2007 Sep;171(3):800-8 [PMID: 17640968]
  3. Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1352-7 [PMID: 12829522]
  4. Kidney Int Suppl. 2003 Oct;(86):S2-8 [PMID: 12969120]
  5. Curr Pharm Des. 2004;10(22):2769-78 [PMID: 15320742]
  6. Fed Proc. 1976 Feb;35(2):181-8 [PMID: 765162]
  7. Am J Hypertens. 1997 May;10(5 Pt 2):83S-88S [PMID: 9160787]
  8. Blood Press. 1998 May;7(3):133-8 [PMID: 9758081]
  9. J Pharmacol Exp Ther. 1999 Feb;288(2):671-8 [PMID: 9918574]
  10. Can J Physiol Pharmacol. 2004 Dec;82(12):1103-12 [PMID: 15644953]
  11. Hypertension. 2005 Feb;45(2):299-310 [PMID: 15611363]
  12. J Cereb Blood Flow Metab. 2005 Mar;25(3):302-13 [PMID: 15647743]
  13. J Immunol. 2005 Jun 1;174(11):7320-9 [PMID: 15905579]
  14. J Immunol. 2000 Dec 1;165(11):6504-10 [PMID: 11086091]
  15. Pharmacol Rev. 2001 Jun;53(2):245-82 [PMID: 11356985]
  16. Am J Physiol Renal Physiol. 2001 Nov;281(5):F795-801 [PMID: 11592936]
  17. Br J Pharmacol. 2002 Jan;135(1):155-69 [PMID: 11786491]
  18. Pharmacol Rev. 2002 Jun;54(2):203-17 [PMID: 12037136]
  19. J Immunol. 2002 Nov 1;169(9):5315-21 [PMID: 12391252]
  20. Am J Pathol. 2002 Nov;161(5):1903-15 [PMID: 12414536]
  21. Atherosclerosis. 2008 May;198(1):57-64 [PMID: 17996873]
  22. J Pharmacol Exp Ther. 2002 Dec;303(3):985-92 [PMID: 12438518]
  23. J Clin Invest. 2003 Jan;111(1):35-41 [PMID: 12511586]
  24. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2106-13 [PMID: 16100037]
  25. J Exp Med. 2006 Feb 20;203(2):425-35 [PMID: 16476770]
  26. J Pharmacol Exp Ther. 2006 Mar;316(3):1017-24 [PMID: 16260582]
  27. J Biol Chem. 2006 Mar 24;281(12):7927-36 [PMID: 16410250]
  28. Blood. 2006 Apr 1;107(7):2736-44 [PMID: 16332977]
  29. J Biol Chem. 2006 Apr 28;281(17):11792-804 [PMID: 16467309]
  30. Blood. 2006 May 15;107(10):3912-21 [PMID: 16434493]
  31. J Pharmacol Sci. 2006;100(5):370-90 [PMID: 16651701]
  32. Biol Chem. 2006 Jun;387(6):817-24 [PMID: 16800746]
  33. Immunol Cell Biol. 2006 Oct;84(5):461-6 [PMID: 16869943]
  34. Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2388-95 [PMID: 16844909]
  35. Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1007-15 [PMID: 17042907]
  36. Br J Pharmacol. 2006 Nov;149(5):591-9 [PMID: 16981001]
  37. Am J Hypertens. 2006 Dec;19(12):1264-9 [PMID: 17161773]
  38. Blood. 2007 Jan 15;109(2):577-83 [PMID: 16990608]
  39. Br J Pharmacol. 2007 Apr;150(8):1044-54 [PMID: 17339845]
  40. Stroke. 2007 May;38(5):1590-6 [PMID: 17379826]
  41. Pflugers Arch. 2007 Jul;454(4):535-43 [PMID: 17318644]
  42. Circ Res. 2007 Aug 3;101(3):268-76 [PMID: 17585070]
  43. J Physiol. 2003 May 15;549(Pt 1):313-25 [PMID: 12665600]

MeSH Term

Angiotensin II
Animals
Blood Pressure
Heart Rate
Infusions, Intravenous
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
Motor Activity
Phenotype
Receptor, PAR-2
Sodium Chloride, Dietary

Chemicals

Receptor, PAR-2
Sodium Chloride, Dietary
Angiotensin II

Word Cloud

Created with Highcharts 10.0.0PAR-2pressures-/-activitybloodpressure01increaseddecreasedlocomotor2angiotensinarterial+/-mmHgheartIIknockoutmiceversusdietP<periodratesintensitysalttimephenotypeweeksn=05higherC57BL/6J33significantlydiastoliccontrolsratehighspentactivelevelssystolicpulsetreatmentresponsesinfusionBACKGROUND:studyusedradiotelemetrymeasurehemodynamicvariablesconsciousunrestrainedmaleProtease-ActivatedReceptororderprovidedetailedassessmentadditiontestedinfluencesalt-sensitivity8%5%NaCl5II-inducedhypertensionmicrogIle5-angiotensinII/kg/min25microl/hsalineRESULTS:Systolic12921statistically124throughout24hbaselineconditionsPulsealsoelevated30whereasHeartdifferentexception23beatspermin001periodsnocturnaldiurnalpatternfounddifferstrainsledSalt-inducedchangeslessC57B/6JAngiotensinextenttrendlowermiddleobservedindividualCONCLUSION:dataindicatedgeneassociatedmodestchangeexhibitedmoderateelevationyetsubtledifferencecourseBloodloadingprotease-activatedreceptorPAR2

Similar Articles

Cited By